Variant report
Variant | esv3401934 |
---|---|
Chromosome Location | chr6:6260753-6263651 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375793444 | chr6:6260785-6260786 | Enhancers Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs182473515 | chr6:6260797-6260798 | Enhancers Weak transcription Bivalent Enhancer Strong transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs527291689 | chr6:6260811-6260812 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs115925549 | chr6:6260812-6260813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs560862685 | chr6:6260826-6260827 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531664313 | chr6:6260831-6260832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs187106412 | chr6:6260838-6260839 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571371388 | chr6:6260876-6260877 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs538802278 | chr6:6260877-6260878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs114234537 | chr6:6260887-6260888 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536117520 | chr6:6260909-6260910 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs527344523 | chr6:6260918-6260919 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368969913 | chr6:6260921-6260922 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs138286202 | chr6:6260922-6260923 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs572097927 | chr6:6260965-6260966 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs536338385 | chr6:6260980-6260981 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs554592607 | chr6:6260984-6260985 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs576006408 | chr6:6261074-6261075 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537378458 | chr6:6261087-6261088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs559174733 | chr6:6261116-6261117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs143002369 | chr6:6261122-6261123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs541572457 | chr6:6261139-6261140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs549415968 | chr6:6261198-6261199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs559977017 | chr6:6261248-6261249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs572214937 | chr6:6261250-6261251 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs542720840 | chr6:6261265-6261266 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs560899476 | chr6:6261267-6261268 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs531300844 | chr6:6261287-6261288 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs182726642 | chr6:6261288-6261289 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs2608858 | chr6:6261335-6261336 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs2608859 | chr6:6261364-6261365 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs144387687 | chr6:6261384-6261385 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs565535555 | chr6:6261444-6261445 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563885651 | chr6:6261480-6261481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs548263409 | chr6:6261484-6261485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs529594370 | chr6:6261495-6261496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs9766026 | chr6:6261536-6261537 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs372684790 | chr6:6261543-6261544 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs558995449 | chr6:6261561-6261562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs571163088 | chr6:6261567-6261568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs112694057 | chr6:6261570-6261571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs553629415 | chr6:6261573-6261574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs145590594 | chr6:6261596-6261597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs542757681 | chr6:6261626-6261627 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148427195 | chr6:6261666-6261667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs35453766 | chr6:6261680-6261681 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115824024 | chr6:6261690-6261691 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543367956 | chr6:6261691-6261692 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188872230 | chr6:6261706-6261707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532485315 | chr6:6261707-6261708 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Developmental delay | 19490664 | CNVD |
Cancer | 21183584 | CNVD |
Multiple Epiphyseal Dysplasia | 20877625 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Glaucoma | 18694899 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 17603634 | CNVD |
Cancer | 20164920 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Prostate cancer | 18632612 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Breast cancer | 21858162 | CNVD |
Lung cancer | 18438408 | CNVD |
Bladder cancer | 21909424 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Gastric cancer | 16891809 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Autism | 22495311 | CNVD |
Autism | 21448237 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 18172304 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 22844521 | CNVD |
HIV/AIDS | 22844521 | CNVD |
Ovarian cancer | 22844521 | CNVD |
Prostate cancer | 22844521 | CNVD |
Psoriasis | 22844521 | CNVD |
Rheumatoid arthritis | 22844521 | CNVD |
Sclerosis systemic | 22844521 | CNVD |
Systemic lupus erythematosus | 22844521 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21552322 | CNVD |
Immune disease | 21076436 | CNVD |
Autoimmune disease | 19135723 | CNVD |
Systemic lupus erythematosus | 17953491 | CNVD |
Recurrent Infections | 22737222 | CNVD |
Systemic lupus erythematosus | 21904924 | CNVD |
Ependymoma | 19289631 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gestational infection | 22844521 | CNVD |
Head circumference | 22844521 | CNVD |
Infertility | 22844521 | CNVD |
Recurrent birth weight diabetes | 22844521 | CNVD |
Obesity | 22844521 | CNVD |
Recurrent pregnancy loss | 22844521 | CNVD |
Intellectual disability | 21811512 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Nasopharyngeal cancer | 22815911 | CNVD |
dysmorphism | 22105932 | CNVD |
psychomotor delay | 22105932 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Melanoma | 20688739 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:6250400-6262600 | Weak transcription | Primary monocytes fromperipheralblood | blood |
2 | chr6:6257800-6267200 | Weak transcription | Placenta | Placenta |
3 | chr6:6258000-6261600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
4 | chr6:6258000-6266400 | Weak transcription | HSMMtube | muscle |
5 | chr6:6260000-6262400 | Weak transcription | Monocytes-CD14+_RO01746 | blood |
6 | chr6:6260200-6260800 | Enhancers | Cortex derived primary cultured neurospheres | brain |
7 | chr6:6260200-6260800 | Enhancers | Gastric | stomach |
8 | chr6:6260200-6260800 | Strong transcription | HSMM | muscle |
9 | chr6:6260400-6260800 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr6:6260400-6261000 | Enhancers | H1 Cell Line | embryonic stem cell |
11 | chr6:6260400-6261000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:6260600-6260800 | Bivalent Enhancer | Stomach Mucosa | stomach |
13 | chr6:6260600-6261000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
14 | chr6:6260600-6261000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
15 | chr6:6260800-6264200 | Weak transcription | HSMM | muscle |
16 | chr6:6262400-6268800 | Strong transcription | Monocytes-CD14+_RO01746 | blood |
17 | chr6:6262600-6263800 | Strong transcription | Primary monocytes fromperipheralblood | blood |